Work

Clinical activity and safety of anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced melanoma (MEL).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8507

Authors: F. Stephen Hodi, Mario Sznol, David F. McDermott, Richard D. Carvajal, Donald P. Lawrence, Suzanne Louise Topalian, Jon Wigginton, Dan McDonald, Georgia Kollia, Ashok Kumar Gupta, Jeffrey Alan Sosman

Institutions: Dana-Farber Cancer Institute, Yale Cancer Center, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Johns Hopkins University, Bristol-Myers Squibb (United States), Vanderbilt University Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589193361

Cites:

Cited by: 15

Related to: 10